| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |